Biznesmen kupuje prawa do leku na AIDS i podwyższa cenę z 13,5 do 750 dolarów
According to the New York Times, Martin Shkreli, 32, the founder and chief executive of Turing Pharmaceuticals, purchased the rights to Daraprim for $55 million on the same day that Turing announced it had raised $90 million from Shkreli and other investors in its first round of financing.
u.....6 z- #
- #
- #
- #
- #
- #
- 216
Komentarze (216)
najlepsze
Jesteście głupi, pozdrawiam !
Komentarz usunięty przez moderatora